The European Medicines Agency has announced a "rolling review" of Russia's Sputnik V coronavirus vaccine. The head of the Russian Direct Investment Fund, which developed Sputnik, said it would be able to provide its vaccine for 50 million Europeans from June if it is approved by the EMA. More to follow